Abdera Therapeutics Unveils Promising Phase 1 Trial Results for ABD-147 at IASLC 2025 World Conference
Abdera Therapeutics presents early pharmacokinetics, dosimetry, and safety data from ongoing Phase 1 trial of…
Abdera Therapeutics presents early pharmacokinetics, dosimetry, and safety data from ongoing Phase 1 trial of…